Skip to content

BIODESIX INC

BDSX

CIK 0001439725

← back to feed
Revenue (TTM)
$85.3M
+24.1% YoY Q1 Apr 2026
Net Income (TTM)
−$39.08M
+17.9% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$3.57
+29.7% YoY Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
-37.6%
Q1 Apr 2026
Net Margin
-45.8%
Q1 Apr 2026
Free Cash Flow (TTM)
−$49.83M
Q1 Apr 2026
Cash
$25.57M
Q1 Apr 2026
Total Debt
$50M
Q1 Apr 2026
Shares Outstanding
10.11M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings